Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Park (Suwon, Republic of Korea), Y. Hong (Chuncheon, Republic of Korea), W. Kim (Chuncheon, Republic of Korea), S. Um (Busan, Republic of Korea), J. Jung (Suwon, Republic of Korea), S. Ahn (Wonju, Republic of Korea), Y. Oh (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea). Blood eosinophil as a biomarker in COPD. 1064

Member's Comments

No comment yet.

Related content which might interest you: The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Blood biomarkers in asthma and COPD Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016 Peripheral eosinophil count as a biomarker for the management of COPD: not there yet Source: Eur Respir J, 50 (5) 1702165; 10.1183/13993003.02165-2017 Year: 2017 Role of blood neutrophilia as a biomarker in asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018 Blood eosinophil counts in COPD patients compared to controls Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019 Year: 2019 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016 Blood eosinophils do not reflect lung tissue eosinophils in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Cytokine profile of blood and sputum in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015